| 23.12 -0.09 (-0.39%) | 11-02 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 27.28 | 1-year : | 31.86 |
| Resists | First : | 23.36 | Second : | 27.28 |
| Pivot price | 18.36  |
|||
| Supports | First : | 17.02 | Second : | 13.1 |
| MAs | MA(5) : | 23.24 |
MA(20) : | 17.21 |
| MA(100) : | 15.42 |
MA(250) : | 15.02 |
|
| MACD | MACD : | 2.4 |
Signal : | 1.5 |
| %K %D | K(14,3) : | 98.3 |
D(3) : | 98.6 |
| RSI | RSI(14): 86 |
|||
| 52-week | High : | 23.36 | Low : | 11.4 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SGRY ] has closed below upper band by 19.8%. Bollinger Bands are 432.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 23.26 - 23.37 | 23.37 - 23.48 |
| Low: | 22.83 - 22.98 | 22.98 - 23.12 |
| Close: | 22.93 - 23.16 | 23.16 - 23.38 |
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Mon, 02 Nov 2026
TD Cowen Downgrades Surgery Partners to Hold From Buy, Price Target is $23.50 - www.marketscreener.com
Mon, 02 Nov 2026
SGRY Legal Notice: Surgery Partners Shareholders Are Notified to - The National Law Review
Fri, 30 Oct 2026
SGRY Investigation Reminder: Surgery Partners’ $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares - WBOC TV
Wed, 28 Oct 2026
Surgery Partners, Inc. (SGRY) stock price, news, quote and history - Yahoo Finance Singapore
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 131 (M) |
| Shares Float | 59 (M) |
| Held by Insiders | 1.7 (%) |
| Held by Institutions | 126.6 (%) |
| Shares Short | 14,350 (K) |
| Shares Short P.Month | 12,950 (K) |
| EPS | -0.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 12.88 |
| Profit Margin | -2.7 % |
| Operating Margin | 13.7 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | 2.3 % |
| Qtrly Rev. Growth | 2.7 % |
| Gross Profit (p.s.) | 5.78 |
| Sales Per Share | 25.74 |
| EBITDA (p.s.) | 4.93 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 258 (M) |
| Levered Free Cash Flow | 184 (M) |
| PE Ratio | -33.62 |
| PEG Ratio | 0 |
| Price to Book value | 1.8 |
| Price to Sales | 0.9 |
| Price to Cash Flow | 11.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|